EPIOXA HD/EPIOXA KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Epioxa Hd/epioxa Kit, and when can generic versions of Epioxa Hd/epioxa Kit launch?
Epioxa Hd/epioxa Kit is a drug marketed by Glaukos and is included in one NDA.
The generic ingredient in EPIOXA HD/EPIOXA KIT is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EPIOXA HD/EPIOXA KIT?
- What are the global sales for EPIOXA HD/EPIOXA KIT?
- What is Average Wholesale Price for EPIOXA HD/EPIOXA KIT?
Summary for EPIOXA HD/EPIOXA KIT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | EPIOXA HD/EPIOXA KIT at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for EPIOXA HD/EPIOXA KIT
Generic Entry Date for EPIOXA HD/EPIOXA KIT*:
Constraining patent/regulatory exclusivity:
NEW PRODUCT NDA:
Dosage:
SOLUTION/DROPS;OPHTHALMIC |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for EPIOXA HD/EPIOXA KIT
EPIOXA HD/EPIOXA KIT is protected by zero US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of EPIOXA HD/EPIOXA KIT is ⤷ Start Trial.
This potential generic entry date is based on NEW PRODUCT.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | EPIOXA HD/EPIOXA KIT | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 219910-001 | Oct 17, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
